Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ESPR
ESPR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ESPR News
Investor Rights Law Firm Investigates Multiple Companies
4d ago
Globenewswire
Esperion Therapeutics to Announce Q1 Earnings on May 7
4d ago
seekingalpha
Investigations into Multiple Biotech Company Mergers
5d ago
Globenewswire
Monteverde Law Firm Investigates Merger Cases
5d ago
Globenewswire
ESPERION THERAPEUTICS INC: NEEDHAM DOWNS RATING TO HOLD FROM BUY
6d ago
moomoo
Investor Rights Law Firm Investigates Multiple Companies
6d ago
PRnewswire
Key Deals Reported Across Sectors This Week
May 03 2026
seekingalpha
Monteverde Law Firm Investigates Esperion Transaction
May 01 2026
Globenewswire
Ademi LLP Investigates Esperion's Transaction Compliance
May 01 2026
PRnewswire
ESPERION THERAPEUTICS STOCK SOARS 57% FOLLOWING ARCHIMED'S $1.1 BILLION ACQUISITION OFFER
May 01 2026
moomoo
Esperion Therapeutics Shares Surge 57% on $1.1 Billion Acquisition by ARCHIMED
May 01 2026
seekingalpha
Esperion to be Acquired at 58% Premium, Shareholders to Receive $3.16
May 01 2026
stocktwits
Esperion to be Acquired by ARCHIMED in $1.1 Billion Deal
May 01 2026
NASDAQ.COM
Esperion Enters Acquisition Agreement with ARCHIMED
May 01 2026
Newsfilter
Esperion Reports 38% Revenue Growth and Enbumyst Launch Plans at Needham Conference
Apr 14 2026
Yahoo Finance
Esperion Outlines Future Growth Plans and Acquisition Strategy
Mar 10 2026
stocktwits
Show More News
